RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Lightstone Ventures
L

Lightstone Ventures portfolio

Lightstone Ventures has 4 portfolio companies on record at Recent Funding, with 2 investments in the last 12 months.

Type: Venture capital.
Portfolio on Recent Funding: 4.
Deals, last 12 months: 2.
Rounds led: 2 of 6.
Capital in their rounds: $426.51M.
Latest deal: Amber Therapeutics · Jul 24, 2026.
About this page

It is a venture capital firm based in Portola Valley, US, founded in 2012. It led 2 of the 6 rounds it joined. Its most recent investment on record is Amber Therapeutics's $100M Series A round in July 2026, alongside NEA, 8VC, Intuitive Ventures and 2 others. By category, its portfolio leans toward Health and bio (4) and Manufacturing and industrial (1). It has co-invested with NEA, Gilde Healthcare and 8VC, most often NEA (3 rounds).

About Lightstone Ventures

Firm type: Venture capital.
Headquarters: Portola Valley, US.
Founded: 2012.
Stages: Pre-Seed, Seed, Series A, Series B, Series C.
Sectors: Biotech, Digital Health, Healthtech, Medical Devices.
Leads rounds: Yes.
Portfolio companies: 71.
Exits: 8.
Rounds led: 1.

Funds raised

FundFund #SizeAnnounced
LLightstone Ventures
Bay Area
Ifirst fund$172M
xconomy.com

What Lightstone Ventures invests in

Lightstone Ventures recent investments

CompanyRoundDateAlongside
AAmber TherapeuticsSeries A · $100MNEA (lead), 8VC, Intuitive Ventures +2
PPsiTheraSeries A · $47.5M · leadEurofarma, Samsara Biocapital (lead), YK Bioventures +1
PProVerumSeries B+ · $80MGilde Healthcare, MVM Life Science Partners (lead), Ireland Strategic Investment Fund +2
AAmber TherapeuticsSeries A · $100MNEA (lead), 8VC, Intuitive Ventures +2
TTagworks PharmaceuticalsSeries A · $65MMeneldor, Gilde Healthcare (lead), Novartis Venture Fund +3
PProVerumSeries A · $34.01M · leadGilde Healthcare (lead), Atlantic Bridge University Fund, Ascentifi

How Lightstone Ventures invests

StageDealsCapital in rounds
Series A 5 83%$346.51M
Series B+ 1 17%$80M
YearDealsCapital in rounds
2022 1 17%$34.01M
2023 1 17%$65M
2024 1 17%$100M
2025 2 33%$127.5M
2026 1 17%$100M

Lightstone Ventures portfolio companies

CompanyRound with Lightstone VenturesTotal raisedLatest raise
AAmber Therapeutics
Health and bio
Series A · $100M$200MJul 24, 2026
Series A
PPsiThera
Health and bio
Series A · $47.5M · lead$47.5MDec 16, 2025
Series A
PProVerum
Health and bio
Series B+ · $80M$118.16MAug 25, 2025
Series B+
TTagworks Pharmaceuticals
Health and bio
Series A · $65M$65MJun 22, 2023
Series A

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Venture funds Lightstone Ventures raised, from the list of new VC funds compiled by Shai Goldman (Brex). Each size links to the article that states it, or to that list where no article was found. All new funds: new VC funds.

Share is of the 6 rounds on Recent Funding that name Lightstone Ventures. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Lightstone Ventures, which is a subset of its real portfolio. API: /api/v1/investors/lightstone-ventures (get a free API key). More: the most active VC firms and new venture capital funds.